- This meeting has passed.
Cancer Center Grand Rounds Series: Advances in Hematologic Malignancies and CAR T-Cell Therapy
December 16, 2020 @ 5:30 pm - 7:00 pm
Advances in Hematologic Malignancies and CAR T-Cell Therapy
Plus: A review of risks for opioid misuse and preventive strategies you can adopt in your practice.
Learning Objectives:
After completing this course, attendees will have improved their skills and strategies with regard to hematologic malignancies. Specifically, they will be able to:
- Describe major advances made over the past two decades in allogeneic hematopoietic cell transplantation (HCT)
- Summarize the impact of COVID-19 on adult HCT volumes
- Discern diseases for which CAR T-cell therapy is approved and in development
- Describe the most common side effects associated with CAR T-cell therapy.
- Review the risks for opioid misuse by patients with cancer
- Develop a strategy for managing opioids in their own clinical practices
To secure your spot, please register in advance.The registration fee for CME credit is $45, but we are offering free registration to the first 20 registrants who use the promo code: First 20 PhysicianAfter registering online, you will receive a confirmation email with information on joining the webinar through Zoom.Individuals who wish to attend without the option for CME credit can register by emailing Kurstan.delRosario@ucsf.edu
“The Case-based Multidisciplinary Management of Cancers Meeting is just one way that ANCO brings together the local oncology community. Through its roles in advocacy and education, ANCO is totally committed to the success of oncologists to help us all deliver high quality cancer care for all of Northern California. This is why I joined the ANCO Board and why every oncologist and cancer organization in Northern California should be a member of ANCO.”
Raymond Liu, MD
The Permanente Medical Group